直 Japanese PDF Font
  • Our Professionals
  • Our Work
  • Our Insights
  • Offices
  • Firm
  • Careers
Finnegan
Henry J. Shikani, Ph.D.
Associate
More
vCard
  • 901 New York Avenue, NW
  • Washington, DC 20001-4413
+1 202 408 4330
henry.shikani@finnegan.com henry.shikani@finnegan.com

Henry J. Shikani, Ph.D.

Associate

  • +1 202 408 4330 +1 202 408 4330
  • henry.shikani@finnegan.com henry.shikani@finnegan.com
  • 901 New York Avenue, NW
  • Washington, DC 20001-4413
  • vCard

Henry Shikani, Ph.D., focuses his practice on patent prosecution, client counseling, post-grant proceedings before the Patent Trial and Appeal Board (PTAB) of the U.S. Patent and Trademark Office (USPTO), patent litigation, and providing opinions in the chemical, pharmaceutical, medical device, biologics and biosimilars, biotechnology, consumer products, software, and business methods fields. 

Henry has significant experience in patent prosecution and patent portfolio management, including opinions and counseling and patent mapping and mining. His experience also includes assisting with inter partes review (IPR) trials, interference proceedings, Section 337 proceedings before the International Trade Commission (ITC) and Abbreviated New Drug Application (ANDA) litigations under the Hatch-Waxman Act.

Henry has a wide range of technical experience, including in the areas of neuropathology, infectious diseases, immunotherapy, cell manufacturing and processing, nasal devices, genetics, electrochemical cells, material sciences, software technology in the healthcare fields, networking devices and wireless communication, catalysis, and financial technology. His graduate dissertation focused on characterizing the pathogenesis of cerebral malaria and identifying therapeutic options to treat the neuropathological syndrome. As a graduate researcher at Johns Hopkins University, he worked on determining the pathogenic mechanisms of encephalitic viruses.

In addition to conducting research, Henry served as a teaching assistant and tutor at Albert Einstein College of Medicine for his graduate program's biochemistry, molecular cell biology, and grant writing courses. While in graduate school, he served as a peer and youth mentor for New York City's iMentor program.

Et Cetera

  • Coauthor, “The Immunotherapy Patent Landscape: Types of patent claims for immunotherapeutic inventions,” IPWatchdog, 2017.
  • National Institutes of Health, Ruth L. Kirschstein National Research Service Award Predoctoral Fellow, 2014-2015.
  • Coauthor. "Human Cryptosporidiosis: A Clinical Perspective," Cryptosporidium: Parasite and Disease, 2014.
  • Coauthor. "Altered Regulation of Akt Signaling with Murine Cerebral Malaria, Effects on Long-Term Neuro-Cognitive Function, Restoration with Lithium Treatment," PLoS One, Oct. 17, 2012.
  • Coauthor. "Cerebral Malaria: We Have Come a Long Way," American Journal of Pathology, Sept. 25, 2012.
  • Coauthor. "The Novel ETA Receptor Antagonist HJP-272 Prevents Cerebral Microvascular Hemorrhage in Cerebral Malaria and Synergistically Improves Survival in Combination with an Artemisinin Derivative," Life Sciences, July 17, 2012.
  • Vaccine Science and Policy Certificate, Johns Hopkins University, 2010.
  • Foreign Language and Linguistics Award for Senior Honors Thesis, Georgetown University, 2008.
  • American Task Force for Lebanon Junior Leadership Recognition Award, 2004.

Insights

Articles

The Immunotherapy Patent Landscape: Types of Patent Claims for Immunotherapeutic Inventions

The Immunotherapy Patent Landscape: Types of Patent Claims for Immunotherapeutic Inventions The Immunotherapy Patent Landscape: Types of Patent Claims for Immunotherapeutic Inventions

August 10, 2017

IPWatchdog
Admissions and Education

Admissions

  • U.S. Patent and Trademark Office
  • District of Columbia

Education

American University, Washington College of Law
J.D., cum laude, 2022
Albert Einstein College of Medicine
Ph.D., Biomedical Sciences, 2015
Johns Hopkins University
Sc.M., Molecular Microbiology and Immunology, 2010
Georgetown University
B.S., French Language, cum laude, 2008

Languages

  • French
  • Spanish

Henry's Practices

AI + Finnegan
AI + Patent
Global IP Enforcement, Litigation, and Trials
Branded Hatch-Waxman (ANDA) Litigation and Trials
Design Rights
ITC Section 337 Investigations and Trials
Patent Litigation and Trials
Pretrial Strategies
Patent Office Invalidation Proceedings
Interferences
PTAB Invalidation Proceedings: IPR and PGR
Prosecution and Portfolio Management
Design Rights
Due Diligence
IP Portfolio Management
Opinions and Counseling
Patent Drafting and Prosecution
Patent Mining and Mapping

Henry's Industries

AI, Electronics, and Information Technology
Artificial Intelligence (AI) and Machine Learning (ML)
Augmented Reality/Virtual Reality (AR/VR)
Web3
Chemicals, Industrials, and Materials
Chemical
Communications
Financial Services and Business Systems
Consumer Goods and Services
Consumer Products
Life Sciences
Biologics
Biotechnology
Medical Device and Diagnostics
Pharmaceutical
Transportation and Logistics
Automotive and Smart Mobility Tech

Due to international data regulations, we’ve updated our privacy policy. Click here to read our privacy policy in full.

  • Privacy
  • Disclaimer
  • Legal Notices
  • Fraud Alert
  • EEO Statement
  • Cookies
  • Contact Us

© 2026 Finnegan, Henderson, Farabow, Garrett & Dunner, LLP